Molecular Influenza Test Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1064658
  • May 2021
  • Medical Devices
  • 118 Pages
The Molecular Influenza Test Market research report comprises of an overall in depth-analysis such as market drivers, opportunities, restraints, latest developments and trends, segmentation of the market, competitive analysis, global as well as regional analysis by showcasing how each of these factors can improve the further growth of the market on an overall perspective. The report also showcases the overall market value which includes the historic data (2018-2019) and forecast data (2020-2028) generated through the revenue (USD Mn)
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered Hoffmann-La Roche, Quidel Corporation, Abbott Laboratories, Becton, Dickinson, and Company, Thermo Fisher Scientific, DiaSorin, bioMérieux,, Quidel Corporation, Thermo Fisher Scientific, Hologic, SA Scientific, ekisui Diagnostics, ioMérieux SA, anaher Corporation, iemens Healthineers, esponse Biomedical
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Coverage
With the beginning of the COVID-19 pandemic in early 2020, all major economies around the world enforced severe lockdown restrictions to curb the spread of the virus. Apart from a few sectors such as healthcare and related essential services, most of the industries suffered tremendously due to inability to function in a normal fashion. Moreover, even some of the essential sectors suffered due to delays caused by supply chain disruptions and other travel complexities. However, with massive vaccination drives in most of the developed economies, some of the economies across the world experienced economic recovery from 2021. The Molecular Influenza Test market is expected to gain momentum in such economies and probably recover some of the losses inflicted in the year 2020. With continued efforts towards curbing the virus in the developing economies, the Molecular Influenza Test market is expected to attain Pre COVID-19 levels by mid-2022.

Molecular Influenza Test Report’s Assessment
The research report is formulated such that it offers a deep understating on the market drivers that are assimilating the growth of the market, the market opportunities that are going to provide future growth factors for the market and the market restraints which showcase the reasons as to why the market can get hampered and dissimilated. All these factors are considered keeping in view the historic and forecast analysis which can enlighten the above mentioned factors.

Thereby at a glance a reader can understand all the factors and prospects of the Molecular Influenza Test market and how it can assimilate and dissimilate based on each of the factors and figures mentioned in the report

Molecular Influenza Test Market Competitive and Premeditated Analysis
In the Molecular Influenza Test report major factors such latest tactical developments, competitors, research and development, participation of each region in the market and the competition among them, the latest news regarding company acquisitions and product launch, revenue of the competitors as well as the key offerings they provide all these factors are mentioned in the report with reasons to justify and understand them in depth.

The readers and purchaser of the Molecular Influenza Test research report can gain a comprehensive understanding of the market competition, the revenue of each major players and their contribution towards the market, attractive proposition analysis is provided in the report which sub divides the segments with respect to the largest segment that has contributed to the market growth and the fastest growing segment based on the size of the market as well as its overall appeal.
 
Major Key Players for Global Molecular Influenza Test Market:
The Molecular Influenza Test market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Hoffmann-La Roche, Quidel Corporation, Abbott Laboratories, Becton, Dickinson, and Company, Thermo Fisher Scientific, DiaSorin, bioMérieux,, Quidel Corporation, Thermo Fisher Scientific, Hologic, SA Scientific, ekisui Diagnostics, ioMérieux SA, anaher Corporation, iemens Healthineers, esponse Biomedical

The Molecular Influenza Test market report showcases vast potentials of growth and assimilation which is going to provide the industry numerous opportunities to grow and generate revenue by understanding the segments and which segment is a potential part to increase the disposable income in the present and upcoming years.

Molecular Influenza Test Market Segmentation Analysis:
Each of the segment is explained in brief along with the revenue it generates for the market based on the historic and forecast data by highlighting the largest segment and the fastest growing segment with reasons to justify it.

The Global segmentation of the Molecular Influenza Test market:
By Test Type
RT-PCR
LAMP
NASBA
TMA
Other
Flu Type
Type A Flu
Type B Flu
Type C Flu.
End-User
Hospitals
Diagnostic Laboratories
Research and Academic Institutes
Contract Research Organizations
CROs

Regional Analysis of the Molecular Influenza Test market:
The Molecular Influenza Test market is dived based on different regions such as North America, Europe, Asia Pacific, Latin America and the Middle East and Africa. And the analysis of each region is provided by highlighting the largest contribution region, the fastest growing region and the factors that is keeping the market active in the other regions is also mentioned in depth. Each regional segment also comprises of the revenue each segment holds in a specific region with reasons to justify the values.

By Regions:
  • North America (U.S and Canada)
  • Europe (U.K., Germany and France)
  • Asia Pacific (China, India and Japan)
  • Latin America (Mexico and Brazil)
  • Middle East and Africa (GCC Countries and South Africa)
 


Major Factors Included and highlighted in the Molecular Influenza Test report are as follows:
  • The overall market value along with historic and future data analysis.
  • The Growth drivers, opportunities and restraints are mention in detail.
  • The size of the entire Molecular Influenza Test market on a global perspective.
  • The CAGR value of the overall market from 2020 to 2028.
  • COVID-19 impact on the Molecular Influenza Test market and how it is coping up with the situation.
  • Major competitors and their contribution towards the market.
  • The segmentation analysis is included which provides a clear picture of the market bifurcation.
  • Tables and graphs that can easily been understood at a glance
  • Latest trends and news related to the Molecular Influenza Test market is included in the report.
Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Molecular Influenza Test market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Molecular Influenza Test market for numerous purposes such as:

     1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

     2. Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Molecular Influenza Test market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Molecular Influenza Test market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

     3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Molecular Influenza Test market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • Hoffmann-La Roche
  • Quidel Corporation
  • Abbott Laboratories
  • Becton, Dickinson, and Company
  • Thermo Fisher Scientific
  • DiaSorin, bioMérieux,
  • Quidel Corporation
  • Thermo Fisher Scientific
  • Hologic
  • SA Scientific
  • ekisui Diagnostics
  • ioMérieux SA
  • anaher Corporation
  • iemens Healthineers
  • esponse Biomedical
  • RT-PCR
  • LAMP
  • NASBA
  • TMA
  • Other
  • Hospitals
  • Diagnostic Laboratories
  • Research and Academic Institutes
  • Contract Research Organizations
  • CROs

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Molecular Influenza Test Market Snapshot
          2.1.1. Global Molecular Influenza Test Market By Test Type,2019
               2.1.1.1.RT-PCR
               2.1.1.2.LAMP
               2.1.1.3.NASBA
               2.1.1.4.TMA
               2.1.1.5.Other
          2.1.2. Global Molecular Influenza Test Market By End-User,2019
               2.1.2.1.Hospitals
               2.1.2.2.Diagnostic Laboratories
               2.1.2.3.Research and Academic Institutes
               2.1.2.4.Contract Research Organizations
               2.1.2.5.CROs
          2.1.3. Global Molecular Influenza Test Market By End-use,2019
          2.1.4. Global Molecular Influenza Test Market By Geography,2019

3. Global Molecular Influenza Test Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Molecular Influenza Test Market Size (US$), By Test Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Test Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Test Type, 2020
     4.2. Global Molecular Influenza Test Market Size (US$), By Test Type, 2018 – 2028

5. Global Molecular Influenza Test Market Size (US$), By End-User, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By End-User, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By End-User, 2020
     5.2. Global Molecular Influenza Test Market Size (US$), By End-User, 2018 – 2028

6. Global Molecular Influenza Test Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Molecular Influenza Test Market Size (US$), By End-use, 2018 – 2028

7. Global Molecular Influenza Test Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Molecular Influenza Test Market Analysis, 2018 – 2028 
          7.2.1. North America Molecular Influenza Test Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Molecular Influenza Test Market Size (US$), By Test Type, 2018 – 2028
          7.2.3. North America Molecular Influenza Test Market Size (US$), By End-User, 2018 – 2028
          7.2.4. North America Molecular Influenza Test Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Molecular Influenza Test Market Analysis, 2018 – 2028 
          7.3.1.  Europe Molecular Influenza Test Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Molecular Influenza Test Market Size (US$), By Test Type, 2018 – 2028
          7.3.3. Europe Molecular Influenza Test Market Size (US$), By End-User, 2018 – 2028
          7.3.4. Europe Molecular Influenza Test Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Molecular Influenza Test Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Molecular Influenza Test Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Molecular Influenza Test Market Size (US$), By Test Type, 2018 – 2028
          7.4.3. Asia Pacific Molecular Influenza Test Market Size (US$), By End-User, 2018 – 2028
          7.4.4. Asia Pacific Molecular Influenza Test Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Molecular Influenza Test Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Molecular Influenza Test Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Molecular Influenza Test Market Size (US$), By Test Type, 2018 – 2028
          7.5.3. Latin America Molecular Influenza Test Market Size (US$), By End-User, 2018 – 2028
          7.5.4. Latin America Molecular Influenza Test Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Molecular Influenza Test Market Analysis, 2018 – 2028 
          7.6.1.  MEA Molecular Influenza Test Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Molecular Influenza Test Market Size (US$), By Test Type, 2018 – 2028
          7.6.3. MEA Molecular Influenza Test Market Size (US$), By End-User, 2018 – 2028
          7.6.4. MEA Molecular Influenza Test Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Molecular Influenza Test Providers
        8.4.1 Hoffmann-La Roche
                8.4.1.1 Business Description
                8.4.1.2 Hoffmann-La Roche Geographic Operations
                8.4.1.3 Hoffmann-La Roche Financial Information
                8.4.1.4 Hoffmann-La Roche Product Positions/Portfolio
                8.4.1.5 Hoffmann-La Roche Key Developments
        8.4.2 Quidel Corporation
                8.4.2.1 Business Description
                8.4.2.2 Quidel Corporation Geographic Operations
                8.4.2.3 Quidel Corporation Financial Information
                8.4.2.4 Quidel Corporation Product Positions/Portfolio
                8.4.2.5 Quidel Corporation Key Developments
        8.4.3 Abbott Laboratories
                8.4.3.1 Business Description
                8.4.3.2 Abbott Laboratories Geographic Operations
                8.4.3.3 Abbott Laboratories Financial Information
                8.4.3.4 Abbott Laboratories Product Positions/Portfolio
                8.4.3.5 Abbott Laboratories Key Developments
        8.4.4 Becton, Dickinson, and Company
                8.4.4.1 Business Description
                8.4.4.2 Becton, Dickinson, and Company Geographic Operations
                8.4.4.3 Becton, Dickinson, and Company Financial Information
                8.4.4.4 Becton, Dickinson, and Company Product Positions/Portfolio
                8.4.4.5 Becton, Dickinson, and Company Key Developments
        8.4.5 Thermo Fisher Scientific
                8.4.5.1 Business Description
                8.4.5.2 Thermo Fisher Scientific Geographic Operations
                8.4.5.3 Thermo Fisher Scientific Financial Information
                8.4.5.4 Thermo Fisher Scientific Product Positions/Portfolio
                8.4.5.5 Thermo Fisher Scientific Key Developments
        8.4.6 DiaSorin, bioMérieux,
                8.4.6.1 Business Description
                8.4.6.2 DiaSorin, bioMérieux, Geographic Operations
                8.4.6.3 DiaSorin, bioMérieux, Financial Information
                8.4.6.4 DiaSorin, bioMérieux, Product Positions/Portfolio
                8.4.6.5 DiaSorin, bioMérieux, Key Developments
        8.4.7 Quidel Corporation
                8.4.7.1 Business Description
                8.4.7.2 Quidel Corporation Geographic Operations
                8.4.7.3 Quidel Corporation Financial Information
                8.4.7.4 Quidel Corporation Product Positions/Portfolio
                8.4.7.5 Quidel Corporation Key Developments
        8.4.8 Thermo Fisher Scientific
                8.4.8.1 Business Description
                8.4.8.2 Thermo Fisher Scientific Geographic Operations
                8.4.8.3 Thermo Fisher Scientific Financial Information
                8.4.8.4 Thermo Fisher Scientific Product Positions/Portfolio
                8.4.8.5 Thermo Fisher Scientific Key Developments
        8.4.9 Hologic
                8.4.9.1 Business Description
                8.4.9.2 Hologic Geographic Operations
                8.4.9.3 Hologic Financial Information
                8.4.9.4 Hologic Product Positions/Portfolio
                8.4.9.5 Hologic Key Developments
        8.4.10 SA Scientific
                8.4.10.1 Business Description
                8.4.10.2 SA Scientific Geographic Operations
                8.4.10.3 SA Scientific Financial Information
                8.4.10.4 SA Scientific Product Positions/Portfolio
                8.4.10.5 SA Scientific Key Developments
        8.4.11 ekisui Diagnostics
                8.4.11.1 Business Description
                8.4.11.2 ekisui Diagnostics Geographic Operations
                8.4.11.3 ekisui Diagnostics Financial Information
                8.4.11.4 ekisui Diagnostics Product Positions/Portfolio
                8.4.11.5 ekisui Diagnostics Key Developments
        8.4.12 ioMérieux SA
                8.4.12.1 Business Description
                8.4.12.2 ioMérieux SA Geographic Operations
                8.4.12.3 ioMérieux SA Financial Information
                8.4.12.4 ioMérieux SA Product Positions/Portfolio
                8.4.12.5 ioMérieux SA Key Developments
        8.4.13 anaher Corporation
                8.4.13.1 Business Description
                8.4.13.2 anaher Corporation Geographic Operations
                8.4.13.3 anaher Corporation Financial Information
                8.4.13.4 anaher Corporation Product Positions/Portfolio
                8.4.13.5 anaher Corporation Key Developments
        8.4.14 iemens Healthineers
                8.4.14.1 Business Description
                8.4.14.2 iemens Healthineers Geographic Operations
                8.4.14.3 iemens Healthineers Financial Information
                8.4.14.4 iemens Healthineers Product Positions/Portfolio
                8.4.14.5 iemens Healthineers Key Developments
        8.4.15 esponse Biomedical
                8.4.15.1 Business Description
                8.4.15.2 esponse Biomedical Geographic Operations
                8.4.15.3 esponse Biomedical Financial Information
                8.4.15.4 esponse Biomedical Product Positions/Portfolio
                8.4.15.5 esponse Biomedical Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Molecular Influenza Test Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Molecular Influenza Test Market Revenue, By Test Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Molecular Influenza Test Market Revenue, By End-User, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Molecular Influenza Test Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Molecular Influenza Test Market Revenue, By Test Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Molecular Influenza Test Market Revenue, By End-User, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Molecular Influenza Test Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Molecular Influenza Test Market Revenue, By Test Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Molecular Influenza Test Market Revenue, By End-User, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Molecular Influenza Test Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Molecular Influenza Test Market Revenue, By Test Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Molecular Influenza Test Market Revenue, By End-User, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Molecular Influenza Test Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Molecular Influenza Test Market Revenue, By Test Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Molecular Influenza Test Market Revenue, By End-User, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Molecular Influenza Test Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Molecular Influenza Test: Market Segmentation 
FIG. 2 Global Molecular Influenza Test Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Molecular Influenza Test Market, By Test Type, 2019 (US$ Mn) 
FIG. 5 Global Molecular Influenza Test Market, By End-User, 2019 (US$ Mn) 
FIG. 6 Global Molecular Influenza Test Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Molecular Influenza Test Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Molecular Influenza Test Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Molecular Influenza Test Providers, 2019
FIG. 11 Global Molecular Influenza Test Market Revenue Contribution, By Test Type, 2019 & 2028 (Value %) 
FIG. 12 Global Molecular Influenza Test Market Revenue Contribution, By End-User, 2019 & 2028 (Value %) 
FIG. 13 Global Molecular Influenza Test Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Molecular Influenza Test Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Molecular Influenza Test Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Molecular Influenza Test Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Molecular Influenza Test Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Molecular Influenza Test Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Molecular Influenza Test market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Molecular Influenza Test Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Molecular Influenza Test Market Value, By Segment1, 2018 – 2028
TABLE  North America Molecular Influenza Test Market Value, By Segment2, 2018 – 2028
TABLE  North America Molecular Influenza Test Market Value, By Country, 2018 – 2028
TABLE  Europe Molecular Influenza Test Market Value, By Segment1, 2018 – 2028
TABLE  Europe Molecular Influenza Test Market Value, By Segment2, 2018 – 2028
TABLE  Europe Molecular Influenza Test Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Molecular Influenza Test Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Molecular Influenza Test Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Molecular Influenza Test Market Value, By Country, 2018 – 2028
TABLE  Latin America Molecular Influenza Test Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Molecular Influenza Test Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Molecular Influenza Test Market Value, By Country, 2018 – 2028
TABLE  MEA Molecular Influenza Test Market Value, By Segment1, 2018 – 2028
TABLE  MEA Molecular Influenza Test Market Value, By Segment2, 2018 – 2028
TABLE  MEA Molecular Influenza Test Market Value, By Country, 2018 – 2028
TABLE  Hoffmann-La Roche: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Quidel Corporation: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Abbott Laboratories: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Becton, Dickinson, and Company: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Thermo Fisher Scientific: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  DiaSorin, bioMérieux,: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Quidel Corporation: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Thermo Fisher Scientific: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Hologic: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  SA Scientific: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  ekisui Diagnostics: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  ioMérieux SA: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  anaher Corporation: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  iemens Healthineers: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  esponse Biomedical: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Molecular Influenza Test Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Molecular Influenza Test Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Molecular Influenza Test Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Molecular Influenza Test Market, By Geography, 2019 (US$ Mn)
FIG.  Global Molecular Influenza Test Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Molecular Influenza Test Providers, 2016
FIG.  Global Molecular Influenza Test Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global LAMP Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global NASBA Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global TMA Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Other Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Molecular Influenza Test Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Diagnostic Laboratories Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Research and Academic Institutes Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Contract Research Organizations Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global CROs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Molecular Influenza Test Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Molecular Influenza Test Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Molecular Influenza Test Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Molecular Influenza Test Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Molecular Influenza Test Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Molecular Influenza Test Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Molecular Influenza Test Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Molecular Influenza Test Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Molecular Influenza Test Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Molecular Influenza Test Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Molecular Influenza Test Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Molecular Influenza Test Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Molecular Influenza Test Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Molecular Influenza Test Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Molecular Influenza Test Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Molecular Influenza Test Market Value, 2018 – 2028, (US$ Mn)